-
公开(公告)号：US10098868B2
公开(公告)日：2018-10-16
申请号：US15475812
申请日：2017-03-31
摘要： The present invention relates to the stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (I), or pharmaceutically acceptable salts of compounds of formula (I). More particularly the present invention relates to the stable pharmaceutical composition of compounds of formula (I) comprising compounds of formula (I) or its pharmaceutically acceptable salts, wherein the pH of the formulation is maintained above 7. formula (I).
-
公开(公告)号：US20170266158A1
公开(公告)日：2017-09-21
申请号：US15475812
申请日：2017-03-31
CPC分类号： A61K31/40 , A61K9/2009 , A61K9/2013
摘要： The present invention relates to the stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (I), or pharmaceutically acceptable salts of compounds of formula (I). More particularly the present invention relates to the stable pharmaceutical composition of compounds of formula (I) comprising compounds of formula (I) or its pharmaceutically acceptable salts, wherein the pH of the formulation is maintained above 7. formula (I)
-
公开(公告)号：US09610277B2
公开(公告)日：2017-04-04
申请号：US14899912
申请日：2014-07-24
CPC分类号： A61K31/40 , A61K9/2009 , A61K9/2013
摘要： The present invention relates to the stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (I), or pharmaceutically acceptable salts of compounds of formula (I). More particularly the present invention relates to the stable pharmaceutical composition of compounds of formula (I) comprising compounds of formula (I) or its pharmaceutically acceptable salts, wherein the pH of the formulation is maintained above 7.
-
公开(公告)号：US20160136131A1
公开(公告)日：2016-05-19
申请号：US14899912
申请日：2014-07-24
IPC分类号： A61K31/40
CPC分类号： A61K31/40 , A61K9/2009 , A61K9/2013
摘要： The present invention relates to the stable pharmaceutical composition of a suitable hypolipidemic agent. Preferably, the present invention discloses novel formulations of the compound of formula (I), or pharmaceutically acceptable salts of compounds of formula (I). More particularly the present invention relates to the stable pharmaceutical composition of compounds of formula (I) comprising compounds of formula (I) or its pharmaceutically acceptable salts, wherein the pH of the formulation is maintained above 7.
摘要翻译： 本发明涉及合适的降血脂药物的稳定药物组合物。 优选地，本发明公开了式（I）化合物或式（I）化合物的药学上可接受的盐的新型制剂。 更具体地说，本发明涉及包含式（I）化合物或其药学上可接受的盐的式（I）化合物的稳定的药物组合物，其中制剂的pH值保持在7以上。
-
-
-
搜索结果
4 条记录 (耗时 0.013 秒)
